KEY FEATURES
| Full Name | Orexin |
|---|---|
| Synonym | HCRT; PPOX; Orexin A; Hypocretin 1; Orexin B; Hypocretin 2; Preproorexin; Hypocretin Neuropeptide Precursor |
| Assay Type | Competitive |
| Reactivity | Human |
| Range | 12.35-1000pg/mL |
| Sensitivity | 5.37pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 50μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human OX in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Human OX. During the reaction, Human OX in the sample or standard competes with a fixed amount of Human OX on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human OX. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Human OX in tested samples can be calculated by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human OX ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 53.31 | 149.13 | 434.08 | 54.85 | 147.86 | 411.48 |
| Standard deviation | 3.73 | 8.13 | 14.15 | 3.57 | 6.56 | 13.09 |
| CV(%) | 6.99 | 5.45 | 3.26 | 6.51 | 4.44 | 3.18 |
RECOVERY
The recovery of Human OX spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 96-110 | 101 |
| EDTA plasma (n=8) | 93-108 | 100 |
| Cell culture media (n=8) | 91-102 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human OX in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with OX ELISA Kits
| HCRTR1 ELISA Kit | publications with OX and HCRTR1 |
| FOS ELISA Kit | publications with OX and FOS |
| TRH ELISA Kit | publications with OX and TRH |
| CCK ELISA Kit | publications with OX and CCK |
Pathways associated with OX ELISA Kit
| Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
| Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway | Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway |
| Disease Pathway | Disease Pathway |
| G Alpha (q) Signalling Events Pathway | G Alpha (q) Signalling Events Pathway |
| GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
| GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
| Gastrin-CREB Signalling Pathway Via PKC And MAPK | Gastrin-CREB Signalling Pathway Via PKC And MAPK |
| Metabolic Disorders Of Biological Oxidation Enzymes Pathway | Metabolic Disorders Of Biological Oxidation Enzymes Pathway |
| Orexin And Neuropeptides FF And QRFP Bind To Their Respective Receptors Pathway | Orexin And Neuropeptides FF And QRFP Bind To Their Respective Receptors Pathway |
| Peptide Ligand-binding Receptors Pathway | Peptide Ligand-binding Receptors Pathway |
Diseases associated with OX ELISA Kit
| Nervous System Diseases | publications with OX and Nervous System Diseases |
| Narcolepsy 1 | publications with OX and Narcolepsy 1 |
| Disease Models, Animal | publications with OX and Disease Models, Animal |
| Bradycardia | publications with OX and Bradycardia |
| Carcinoma | publications with OX and Carcinoma |
| Cardiovascular Diseases | publications with OX and Cardiovascular Diseases |
| Pain | publications with OX and Pain |
| Anxiety Disorders | publications with OX and Anxiety Disorders |
| Adenocarcinoma | publications with OX and Adenocarcinoma |
| Intestinal Diseases | publications with OX and Intestinal Diseases |
Organs/Tissues associated with OX ELISA Kit
| Brain | publications with OX and Brain |
| Connective Tissue | publications with OX and Connective Tissue |